Drug composition for treating diabetes and preparing method thereof

Abstract

The invention relates to a drug for adjusting glucose and lipid metabolism disorders and treating diabetes and chronic vascular complications thereof and a preparing method of the drug, and belongs tothe field of traditional Chinese medicine. The drug is prepared from, by weight, 3-9 parts of radix astragali, 3-9 parts of rhizoma polygonati, 2-6 parts of cortex lycii radicis and 2-6 parts of cortex moutan. The preparing method of the drug comprises the steps of a, weighing the radix astragali, rhizoma polygonati, cortex lycii radicis and cortex moutan separately according to the weight ratioof (3-9):(3-9):(2-6):(2-6) for use; b, conducting water extraction and alcohol precipitation or certain-concentration ethyl alcohol backflow on the medicinal materials separately, and then conductingconcentrating to obtain an extract; c, adding the extract into an ingredient, and conducting processing and shaping. The drug has the functions of tonifying qi and nourishing yin, clearing heat and activating blood, and has outstanding curative effects of treating the type-2 diabetes glucose and lipid metabolism disorders and the chronic microvascular complications thereof.

Description

[technical field] [0001] The invention relates to a medicine for regulating glucose and lipid metabolism disorder for treating diabetes and its chronic vascular complications, and a preparation method of the medicine, belonging to the field of traditional Chinese medicine. [Background technique] [0002] Diabetes is a common endocrine and metabolic disorder, which belongs to the category of "diabetes" in traditional Chinese medicine. With the aging of the world's population, diabetes has become a common and frequently-occurring disease, and more than 90% of them are type 2 diabetes (non-insulin-dependent diabetes). In 2008, the International Diabetes Federation estimated that by 2025, the number of diabetic patients aged 20 to 79 in the world will reach 380 million. However, by 2015, the number of diabetic patients aged 20 to 79 in the world has reached 415 million, and the growth rate has far exceeded expectations. Among them, the number of patients in my country has reache...

AI Technical Summary

Problems solved by technology

Although Xiaoke Pills currently on the market have an annual sales of over 100 million yuan and are the main product of Chinese patent medicines for hypoglycemia, Xiaoke Pills are a mixture of Chinese and Western medicines. Long-term and large-scale use may cause side effects of "hypoglycemia" and have adverse effects on diabetic blood vessels. Complications have no apparent effect

Images